Skip to main content
Weiter zur Homepage der Europäischen Kommission (öffnet in neuem Fenster)
Deutsch de
CORDIS - Forschungsergebnisse der EU
CORDIS

TWINNING ON DNA-BASED CANCER VACCINES

Ziel

The objective of this Twinning project is to significantly strengthen the research in Riga Stradins University (RSU; Latvia) in the smart specialization area of Latvia “bio-medicine, medical technologies, and biotechnologies” with application to immunotherapy of cancer through building an up-rising connections with two internationally leading research institutions, Institute of Microbiology, Tumor and Cell Biology, Karolinska Institutet (Sweden) and the Department of General Biophysics, University of Lodz (Poland). Both represent centers of excellence in the design, testing and clinical applications of a wide class of immunotherapeuticals, with focus on technologies exploiting naked nucleic acids.

Wissenschaftliches Gebiet (EuroSciVoc)

Schlüsselbegriffe

Programm/Programme

Thema/Themen

Finanzierungsplan

CSA - Coordination and support action

Alle im Rahmen dieses Finanzierungsinstruments finanzierten Projekte anzeigen

Aufforderung zur Vorschlagseinreichung

(öffnet in neuem Fenster) H2020-TWINN-2015

Alle im Rahmen dieser Aufforderung zur Einreichung von Vorschlägen finanzierten Projekte anzeigen

Koordinator

RIGAS STRADINA UNIVERSITATE
Netto-EU-Beitrag
€ 357 575,00
Gesamtkosten
€ 357 575,00

Beteiligte (3)